Wednesday, October 04, 2017 11:14:36 AM
I don't think that they will release anything that is materially significant during a presentation. At least that's how the rules are written for US companies. Providing those who attend a conference like that with new information that could significantly affect the share price would give them an unfair advantage. All significant information has to be made public for everyone at the same time.
I do however expect them to make some public statement about the commencement of the trial. Especially since there has been delays. Healios has to inform their investors to let them know that everything is back on track.
They could wait until they have the first enrollment.
After that we should have a revised estimate for the results of the primary endpoint based on the progress of enrollment. Their CEO mentioned that he planed to do an update during his ER presentation.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM